Erika Kleiderman is a lawyer and an Academic Associate at the Centre of Genomics and Policy (CGP) at McGill University. She holds a civil law degree (LL.B.) from the Université de Montréal, as well as a B.Sc. in Psychology from McGill University. She was called to the Quebec Bar in 2014.
Her research focuses on the ethical, legal, and social implications surrounding access to data and genetic information, biobanking, human genome editing, new assisted reproductive technologies, as well as the regulation of stem cell research, and cell and gene therapies. Erika is actively engaged in the stem cell and regenerative medicine community through her involvement with the Stem Cell Network’s Trainee Communications and Training & Education Committees, as well as through her coordination role in the pan-Canadian initiative aimed at assessing the adequacy of existing regulatory frameworks and considerations for reframing the Assisted Human Reproduction Act, in light of evolving assisted reproductive technologies.
She was also the Coordinator of the Canadian International Data Sharing Initiative (Can-SHARE) (2015-2019) and the Access Officer of the Canadian Partnership for Tomorrow Project (CPTP) (2018-2019), for which she was actively involved in the development of controlled data and biosample access documentation and operating procedures. Erika is also interested in the potential applications of gene editing for performance enhancement (gene doping), as well as the implications of gene therapy and enhancement in minors within a sporting context.
She is a member of CIHR’s Stem Cell Oversight Committee and the McGill University Health Centre Research Ethics Board.
Human Genome Editing, Assisted Reproductive Technologies, Cell & Gene Therapies, Data & Biosample Access and Governance, Paediatrics, Regenerative Medicine, Stem Cell Research